Skip to content

CASCCASCADIAN THERAPEUTICS INC

CUSIP 14740B606 · common stock

No tracked investor reported shares of CASCADIAN THERAPEUTICS INC (CASC) for Q1 2018. Seth Klarman sold out of its position this quarter.

Holders · Q1 2018
0
New holders
0
Value held
$0
Quarter-end price (est.)
—

Investors holding CASC · Q1 2018

No tracked investor reported shares this quarter.

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Seth Klarman0.32%8,721,079$32.3MEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q1 2018001$0—
Q4 2017100$32.3M$3.70
Q3 2017100$35.7M$4.09
Q2 2017100$32.4M$3.72
Q1 2017100$36.1M$4.14
Q4 2016110$18M$4.31